Phase 1 Trial of a novel transvenous phrenic nerve pacer for diaphragm activation in mechanically ventilated critically ill patients.
Phase 1 Trial of a novel transvenous phrenic nerve pacer for diaphragm activation in mechanically ventilated critically ill patients.
新型经静脉膈神经起搏器用于机械通气危重患者膈肌激活的一期试验。
批准号：
268523
负责人：
Reynolds Steven C
金额：
$11.54万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-09-01 至 2013-09-01
中文摘要
翻译
机械通气是重症监护病房(ICU)的基础，是一种挽救生命的技术，但它是一把双刃剑，会导致直接和间接的肺损伤，并可迅速导致横隔肌无力和功能障碍。关爱
英文摘要
Mechanical ventilation is a life-saving technology upon which the intensive care unit (ICU) is based; yet, it is a double-edged sword which induces direct and indirect lung damage and can rapidly lead to diaphragmatic weakness and dysfunction. Caring for
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a novel, temporary, transcutaneously placed, transvenous phrenic nerve pacer for diaphragm activation in critically ill patients
-
批准号：315085
-
项目类别：Operating Grants
-
资助金额：$19.56万
-
财政年份：2014
-
负责人：Reynolds Steven C
-
依托单位：
海外基金